Detalhe da pesquisa
1.
Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin Amyloid.
N Engl J Med;
389(3): 239-250, 2023 Jul 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37212440
2.
Antibody NI006 for Cardiac Transthyretin Amyloid Depletion. Reply.
N Engl J Med;
389(13): 1249, 2023 Sep 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37754296
3.
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.
N Engl J Med;
378(7): 615-624, 2018 Feb 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29231094
4.
Edoxaban versus warfarin in patients with atrial fibrillation in relation to the risk of stroke: A secondary analysis of the ENGAGE AF-TIMI 48 study.
Am Heart J;
235: 132-139, 2021 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33493453
5.
Comparison of Events Across Bleeding Scales in the ENGAGE AF-TIMI 48 Trial.
Circulation;
140(22): 1792-1801, 2019 11 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31597460
6.
Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48.
Circulation;
139(6): 760-771, 2019 02 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30586727
7.
Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial.
Eur Heart J;
40(19): 1541-1550, 2019 05 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30624719
8.
Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trial.
Eur Heart J;
40(19): 1518-1527, 2019 05 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30590425
9.
Linking Endogenous Factor Xa Activity, a Biologically Relevant Pharmacodynamic Marker, to Edoxaban Plasma Concentrations and Clinical Outcomes in the ENGAGE AF-TIMI 48 Trial.
Circulation;
138(18): 1963-1973, 2018 10 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29967197
10.
Edoxaban and implantable cardiac device interventions: insights from the ENGAGE AF-TIMI 48 trial.
Europace;
21(2): 306-312, 2019 Feb 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30462220
11.
A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trial.
Eur Heart J;
38(12): 888-896, 2017 Mar 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28064150
12.
Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial.
Lancet;
388(10055): 1995-2003, 2016 Oct 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27590218
13.
Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events: Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48).
Stroke;
47(8): 2075-82, 2016 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27387994
14.
Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial.
Lancet;
385(9984): 2280-7, 2015 Jun 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25769357
15.
Edoxaban vs warfarin in patients with nonvalvular atrial fibrillation in the US Food and Drug Administration approval population: An analysis from the Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48 (ENGAGE AF-TIMI 48) trial.
Am Heart J;
172: 144-51, 2016 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26856226
16.
Nonvitamin K antagonist oral anticoagulant activity: challenges in measurement and reversal.
Crit Care;
20(1): 273, 2016 Sep 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27659071
17.
Edoxaban vs. warfarin in vitamin K antagonist experienced and naive patients with atrial fibrillation.
Eur Heart J;
36(23): 1470-7, 2015 Jun 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25687352
18.
Application of the Win Ratio Method in the ENGAGE AF-TIMI 48 Trial Comparing Edoxaban With Warfarin in Patients With Atrial Fibrillation.
Circ Cardiovasc Qual Outcomes;
: e010561, 2024 Jun 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38828563
19.
Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves.
Circulation;
135(13): 1273-1275, 2017 03 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28209729
20.
Pharmacogenetic-guided and clinical warfarin dosing algorithm assessments with bleeding outcomes risk-stratified by genetic and covariate subgroups.
Int J Cardiol;
317: 159-166, 2020 Oct 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32505370